Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMedifast Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q2 2026 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q3 2026 | 1 | -$0.38 | -$0.38 | -$0.38 |
| Q4 2026 | 1 | -$0.65 | -$0.65 | -$0.65 |
| Q1 2027 | 1 | -$0.65 | -$0.65 | -$0.65 |
| Q2 2027 | 1 | -$0.63 | -$0.63 | -$0.63 |
| Q3 2027 | 1 | -$0.61 | -$0.61 | -$0.61 |
| Q4 2027 | 1 | -$0.87 | -$0.87 | -$0.87 |
Medifast Inc Earnings Date And Information
Medifast Inc last posted its earnings results on Monday, May 4th, 2026. The company reported $-0.19 earnings per share for the quarter, topping analysts' consensus estimates of $-0.55 by $0.36. The company had revenue of 76.04 M for the quarter and had revenue of 385.79 M for the year. Medifast Inc has generated $-2 earnings per share over the last year ($-1.7 diluted earnings per share) and currently has a price-to-earnings ratio of -6.98. Medifast Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Medifast Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/04/2026 | Q1 2026 | -$0.55 | -$0.19 | 0.36 | $69.20 M | $76.04 M |
| 02/17/2026 | Q4 2025 | -$0.76 | -$1.65 | -0.89 | $71.40 M | $75.10 M |
| 11/03/2025 | Q3 2025 | -$0.01 | -$0.21 | -0.2 | $89.70 M | $89.41 M |
| 08/04/2025 | Q2 2025 | -$0.30 | $0.23 | 0.53 | $101.80 M | $105.56 M |
| 04/28/2025 | Q1 2025 | -$0.07 | -$0.07 | 0 | $116.40 M | $115.73 M |
| 02/18/2025 | Q4 2024 | -$0.16 | $0.07 | 0.23 | $118.05 M | $119.00 M |
| 11/04/2024 | Q3 2024 | -$0.15 | $0.10 | 0.25 | $138.15 M | $140.16 M |
| 08/05/2024 | Q2 2024 | $0.36 | -$0.75 | -1.11 | $174.05 M | $168.56 M |
| 04/29/2024 | Q1 2024 | $0.78 | $0.76 | -0.02 | $173.45 M | $174.74 M |
| 02/20/2024 | Q4 2023 | $0.99 | $0.50 | -0.49 | N/A | $191.02 M |
| 11/06/2023 | Q3 2023 | $1.07 | $2.12 | 1.05 | N/A | $235.87 M |
| 08/07/2023 | Q2 2023 | $1.44 | $2.78 | 1.34 | N/A | $296.19 M |
| 05/01/2023 | Q1 2023 | $2.40 | $3.68 | 1.28 | N/A | $348.98 M |
| 02/21/2023 | Q4 2022 | $2.18 | $2.40 | 0.22 | N/A | $337.25 M |
| 11/03/2022 | Q3 2022 | $1.91 | $3.30 | 1.39 | N/A | $390.40 M |
| 08/03/2022 | Q2 2022 | $3.23 | $3.44 | 0.21 | N/A | $453.33 M |
| 05/02/2022 | Q1 2022 | $3.57 | $3.62 | 0.05 | N/A | $417.60 M |
| 02/23/2022 | Q4 2021 | $2.65 | $2.91 | 0.26 | N/A | $377.83 M |
| 11/04/2021 | Q3 2021 | $3.08 | $3.59 | 0.51 | N/A | $413.40 M |
| 08/04/2021 | Q2 2021 | $3.32 | $4.00 | 0.68 | N/A | $394.19 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Medifast Inc Earnings: FAQ's
In the previous quarter, Medifast Inc (:MED) reported $-0.19 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.55 by $0.36.
The conference call for Medifast Inc's latest earnings report can be listened to online.
The conference call transcript for Medifast Inc's latest earnings report can be read online.
Medifast Inc (:MED) has a recorded annual revenue of $385.79 M.
Medifast Inc (:MED) has a recorded net income of $-18,672,000.Medifast Inc has generated $-1.7 earnings per share over the last four quarters.
Medifast Inc (:MED) has a price-to-earnings ratio of -6.98 and price/earnings-to-growth ratio is 0.01.